INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 30 filers reported holding INTEC PHARMA LTD JERUSALEM in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $0 | – | 3,300 | +37.5% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 2,400 | -4.0% | 0.00% | – |
| Q4 2019 | $1,000 | -91.7% | 2,500 | -85.4% | 0.00% | – |
| Q3 2019 | $12,000 | -89.4% | 17,132 | -34.5% | 0.00% | – |
| Q2 2019 | $113,000 | -80.9% | 26,164 | -67.6% | 0.00% | -100.0% |
| Q1 2019 | $591,000 | +71.8% | 80,641 | +76.8% | 0.00% | +100.0% |
| Q4 2018 | $344,000 | – | 45,624 | +87638.5% | 0.00% | – |
| Q3 2018 | $0 | – | 52 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 630,000 | $3,528,000 | 1.74% |
| DAFNA Capital Management LLC | 135,000 | $756,000 | 0.75% |
| Cormorant Asset Management, LP | 800,000 | $4,480,000 | 0.72% |
| Perceptive Advisors | 700,000 | $3,920,000 | 0.16% |
| SABBY MANAGEMENT, LLC | 613,910 | $3,438,000 | 0.14% |
| Ion Asset Management Ltd. | 10,000 | $56,000 | 0.08% |
| JANE STREET GROUP, LLC | 34,317 | $194,000 | 0.00% |
| UBS Group AG | 1,296 | $7,000 | 0.00% |